Hemodiafiltration during cardiac surgery in patients on chronic hemodialysis

Atsushi Fukumoto1, Masaaki Yamagishi, Kiyoshi Doi

  • 1Department of Cardiovascular and Thoracic Surgery, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, 465 Kaiji-cho, Kawaramachi-Hirokoji, Kamigyo-ku, Kyoto 602-8566, Japan. fukumoto@koto.kpu-m.ac.jp

Insights

Intraoperative hemodiafiltration (HDF) in chronic dialysis patients undergoing cardiac surgery significantly reduced postoperative complications and mortality. This innovative HDF protocol also enabled earlier patient extubation and ambulation, leading to shorter hospital stays.

Area of Science:

  • Nephrology
  • Cardiovascular Surgery
  • Critical Care Medicine

Background:

  • Patients on chronic hemodialysis undergoing cardiac surgery face risks of fluid imbalance and bleeding.
  • A novel hemodiafiltration (HDF) protocol was developed to manage these risks.
  • This study retrospectively evaluated the outcomes of this HDF protocol.

Purpose of the Study:

  • To assess the efficacy of an intraoperative hemodiafiltration (HDF) protocol.
  • To evaluate its impact on postoperative morbidity and mortality in patients on chronic dialysis undergoing cardiac surgery.

Main Methods:

  • Retrospective study of 33 chronic dialysis patients undergoing cardiac surgery (including 19 off-pump CABG).
  • Vascular access via femoral vein catheter; HDF initiated at surgery start.
  • HDF continued post-procedure to achieve target hematocrit, CVP, and serum potassium levels.

Main Results:

  • Zero in-hospital mortality observed.
  • No instances of postoperative wound infection, mediastinitis, respiratory tract infection, or hemorrhage.
  • Patients discharged at a mean of 15.6 days post-operation.

Conclusions:

  • Intraoperative HDF appears to reduce postoperative morbidity and mortality in chronic dialysis patients.
  • The protocol facilitates early extubation and ambulation.
  • Shortened hospitalization duration is a significant benefit.
Abstract

Related Concept Videos

Hemodialysis II: Procedure and Complications01:24

Hemodialysis II: Procedure and Complications

DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
Hemodialysis I: Introduction01:25

Hemodialysis I: Introduction

Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...
Hemodialysis III: Nursing Management01:25

Hemodialysis III: Nursing Management

The nursing management of a patient undergoing hemodialysis includes several critical steps, starting with a thorough assessment before the procedure.Before the Hemodialysis ProcedureFirst, record the patient's vital signs—blood pressure, heart rate, respiratory rate, and temperature—to establish a baseline. This baseline is essential for detecting conditions such as hypotension that could impact the patient's response to dialysis. Document the patient's pre-dialysis weight, as this measurement...
Extracorporeal Removal of Drugs: Hemoperfusion and Hemofiltration01:25

Extracorporeal Removal of Drugs: Hemoperfusion and Hemofiltration

Hemoperfusion and hemofiltration are critical techniques in medical treatments to eliminate accumulated drugs, metabolites, and electrolytes from the bloodstream. These methods are particularly vital in cases of accidental poisoning and drug overdose.Hemoperfusion involves passing blood through an adsorbent material to remove unwanted substances. The main adsorbents used in hemoperfusion include activated charcoal and Amberlite resins. Activated charcoal can adsorb both polar and nonpolar...
Continuous Renal Replacement Therapy01:30

Continuous Renal Replacement Therapy

Continuous Renal Replacement Therapy, also known as CRRT, is a procedural treatment for acute kidney injury (AKI) that gradually removes uremic toxins and fluids while maintaining acid-base balance and stabilizing electrolytes. It is particularly useful for hemodynamically unstable patients. Unlike intermittent hemodialysis, which is faster, CRRT provides a gentler approach over 24 hours, closely mimicking the function of natural kidneys. However, CRRT is not ideal for patients with...
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy01:26

Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy

Continuous Renal Replacement Therapy (CRRT) is an essential intervention for patients experiencing severe kidney dysfunction. This therapy offers a continuous mechanism for removing fluids and toxins from the bloodstream, leveraging the patient’s blood pressure to facilitate filtration through a specialized filter. This method contrasts with intermittent dialysis, providing a gentler and more consistent removal of waste products and excess fluid, which is particularly beneficial in critically...